Ebola and Marburg Hemorrhagic Fever

被引:102
作者
Hartman, Amy L. [1 ,2 ]
Towner, Jonathan S. [3 ]
Nichol, Stuart T. [3 ]
机构
[1] Univ Pittsburgh, Reg Biocontainment Lab, Ctr Vaccine Res, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA
[3] Ctr Dis Control & Prevent, Special Pathogens Branch, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA
关键词
Ebola; Marburg; Filovirus; Hemorrhagic fever; VIRUS-LIKE PARTICLES; NONHUMAN-PRIMATES; DENDRITIC CELLS; POSTEXPOSURE TREATMENT; ENDOTHELIAL-CELLS; RHESUS-MONKEYS; TISSUE FACTOR; GUINEA-PIGS; IN-VITRO; INFECTION;
D O I
10.1016/j.cll.2009.12.001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Ebola and Marburg viruses cause a severe viral hemorrhagic fever disease mainly in Sub-Saharan Africa. Although outbreaks are sporadic, there is the potential for filoviruses to spread to other continents unintentionally because of air travel or intentionally because of bioterrorism. This article discusses the natural history, epidemiology, and clinical presentation of patients infected with Ebola and Marburg viruses. Clinicians in the United States should be aware of the symptoms of these viral infections in humans and know the appropriate procedures for contacting local, state, and national reference laboratories in the event of a suspected case of filoviral hemorrhagic fever.
引用
收藏
页码:161 / +
页数:19
相关论文
共 62 条
  • [31] HUGGINS JW, 1989, REV INFECT DIS, V11, pS750
  • [32] Inactivated Marburg virus elicits a nonprotective immune response in rhesus monkeys
    Ignatyev, GM
    Agafonov, AP
    Streltsova, MA
    Kashentseva, EA
    [J]. JOURNAL OF BIOTECHNOLOGY, 1996, 44 (1-3) : 111 - 118
  • [33] Evaluation of immune globulin and recombinant interferon-α2b for treatment of experimental Ebola virus infections
    Jahrling, PB
    Geisbert, TW
    Geisbert, JB
    Swearengen, JR
    Bray, M
    Jaax, NK
    Huggins, JW
    LeDuc, JW
    Peters, CJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 : S224 - S234
  • [34] Jahrling PB, 1996, ARCH VIROL, P135
  • [35] Ebola hemorrhagic fever: Evaluation of passive immunotherapy in nonhuman primates
    Jahrling, Peter B.
    Geisbert, Joan B.
    Swearengen, James R.
    Larsen, Thomas
    Geisbert, Thomas W.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 196 : S400 - S403
  • [36] Interventions to control virus transmission during an outbreak of Ebola hemorrhagic fever:: Experience from Kikwit, Democratic Republic of the Congo, 1995
    Kerstiëns, B
    Matthys, F
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 : S263 - S267
  • [37] Clinical virology of Ebola hemorrhagic fever (EHF): Virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995
    Ksiazek, TG
    Rollin, PE
    Williams, AJ
    Bressler, DS
    Martin, ML
    Swanepoel, R
    Burt, FJ
    Leman, PA
    Khan, AS
    Rowe, AK
    Mukunu, R
    Sanchez, A
    Peters, CJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 : S177 - S187
  • [38] Impairment of dendritic cells and adaptive immunity by Ebola and lassa viruses
    Mahanty, S
    Hutchinson, K
    Agarwal, S
    Mcrae, M
    Rollin, PE
    Pulendran, B
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (06) : 2797 - 2801
  • [39] Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients
    Mupapa, K
    Massamba, M
    Kibadi, K
    Kuvula, K
    Bwaka, A
    Kipasa, M
    Colebunders, R
    Muyembe-Tamfum, JJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 : S18 - S23
  • [40] Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys
    Oswald, Wendelien B.
    Geisbert, Thomas W.
    Davis, Kelly J.
    Geisbert, Joan B.
    Sullivan, Nancy J.
    Jahrling, Peter B.
    Parren, Paul W. H. I.
    Burton, Dennis R.
    [J]. PLOS PATHOGENS, 2007, 3 (01) : 62 - 66